OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing... Read more
Org chart
Teams
Offices
Aspect Biosystems
1 follower
STEMCELL Technologies
15 followers
Clinion
1 follower
REVOLUTION Medicines
19 followers
ProcDNA
1 follower
Freenome
10 followers
Halozyme Therapeutics
10 followers
Telix Pharma
8 followers
4D Molecular Therapeutics
8 followers
Kymera Therapeutics
7 followers
Beta Bionics
5 followers
Micro Crispr Pvt. Ltd.
1 follower